| Amicus Therapeutics Switzerland GmbH - Opfolda 65 mg, Hartkapseln | | 67806 | | 01 | | Opfolda 65 mg | | Hartkapseln | | A16AX06 | | Miglustat | | 04.07.2024 | | |
| | Composition | | Kapsel: miglustatum 65 mg, cellulosum microcristallinum, maydis amylum, sucralosum, magnesii stearas, silica colloidalis anhydrica, Kapselhülle: gelatina, E 171, E 172 (nigrum), Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, E 172 (nigrum), pro capsula. | | Packungsbestandteile | | Capsules | | | | | Active Agent | Dose | additional_information |
|---|
| Miglustate | 65 mg | Kapsel |
| | BAG: Active Agent | Dose |
|---|
| Miglustate | 65 mg |
| | | | Inactive agents | | additional_information |
|---|
| | | | | | | | | | | | | | | color. | | | | color. | | Gelatina | | Kapselhülle | | | | | | | | Drucktinte | | | | | | | | | | | | | | Propylenglycol | | | | Silica Colloidalis Anhydrica | | | | | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 4 | PR | PR | B | | Yes | | 002 | 24 | 1005.78 | 1110.25 | B | SL | No |
|
|
